Cholangiocarcinoma

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

TCR1188-ABC Cells in KRAS-mutated Cancers

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

IKS04 Regimen in Advanced Solid Tumors That Express CA242

An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma

Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study

Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Safety and Efficacy of EUS-guided Gallbladder Drainage Under Endoscopist-directed Conscious Sedation

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma